Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Impad1 and Syt11 work in an epistatic pathway that regulates EMT-mediated vesicular trafficking to drive lung cancer invasion and metastasis

Cell Reports(2022)10.1016/j.celrep.2022.111429Source: DataRank Database

Impad1 and Syt11 work in an epistatic pathway that regulates EMT-mediated vesicular trafficking to drive lung cancer invasion and metastasis is a research paper published in Cell Reports (2022). On theSindex it has a DataRank of 0. It has been cited 17 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access17 citations

Download PDF

Cite:

Linked data & code

hpa

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (15 grants)OA: goldTopics (39)IDs (PubMed, PMC)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (15)

B. Leticia Rodriguez ORCID,William K. Russell ORCID,Amanda N. Warner ORCID,Lixia Diao ORCID,Jing Wang ORCID

Live enrichment

PubMed:36170810 PMC:PMC9665355

Cancer Prevention and Research Institute of Texas

Grant: RP170067

Cancer Prevention and Research Institute of Texas

Grant: RP190682

National Institutes of Health

Grant: CPRIT-MIRA RP160652-P3

NCI

Grant: R37CA214609

NCI NIH HHS

Grant: P30 CA016672

NCI NIH HHS

Grant: P50 CA070907

National Institutes of Health

Grant: 3P50CA070907-02S1

UNIVERSITY OF TEXAS--SPORE IN LUNG CANCER

National Institutes of Health

Grant: 3P30CA016672-41S4

Cancer Center Support (CORE) Grant

National Institutes of Health

Grant: 5R37CA214609-07

The Role of Epithelial-Mesenchymal Transition in Re-Wiring KRAS Mutant Lung Cancer

Janssen Pharmaceuticals

AstraZeneca

Rexanna's Foundation

Eli Lilly and Company

Astellas Pharma US

Ribon Therapeutics

goldLicense: CC BY NC ND

publisherhttp://www.cell.com/article/S2211124722012700/pdf

publisherhttps://api.elsevier.com/content/article/PII:S2211124722012700?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2211124722012700?httpAccept=text/plain

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/9665355

Europe_PMChttps://europepmc.org/articles/PMC9665355

Fields of Study

0301 basic medicine0303 health sciences03 medical and health sciences

MeSH Terms

Cell Line, TumorHumansLung NeoplasmsNeoplasm InvasivenessNeoplasm MetastasisMicroRNAsCell MovementGene Expression Regulation, NeoplasticSynaptotagminsEpithelial-Mesenchymal TransitionTumor Microenvironment

Keywords

Extracellular matrixLung cancerInvasionMetastasisTumor MicroenvironmentEpithelial-to-mesenchymal TransitionVesicular TraffickingSecretomeSyt11Tumor Immune MicroenvironmentGolgi MorphologyImpad1Cp: CancerGolgi ExocytosisEpithelial-Mesenchymal TransitionLung NeoplasmsArticleGene Expression Regulation, NeoplasticMicroRNAsSynaptotagminsCell MovementCell Line, TumorHumansNeoplasm InvasivenessNeoplasm Metastasis

Sustainable Development Goals

SDG 3: 3. Good health

Impad1 and Syt11 work in an epistatic pathway that regulates EMT-mediated vesicular trafficking to drive lung cancer invasion and metastasis

FAIR Checklist

Authors (15)

Funding (15 grants)

Open Access

Topics

Annotations (Europe PMC)